The majority of myelin-specific responses was directed towards MOG epitopes both in MS patients (19 out of 28 positive responses) and in healthy volunteers (9 out of 18 positive responses), with MOG64–86 being the peptide recognized most in all study subjects. Here, MOG is linked to myeloid sarcoma.